U2BIO CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,680 KRW | -1.08% |
|
-6.84% | -30.30% |
| 2023 | U2Bio Co., Ltd. has filed an IPO. | CI |
| 2020 | Chang Moo Jeon acquired 8.5% stake in U2Bio CO. LTD. from MAC Fund, L.P. (Class B), a fund managed by M-Venture Investment, Inc. for KRW 1.6 billion. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| U2BIO CO., LTD. | Other Healthcare Facilities & Services | -1.08% | -6.84% | -30.30% | -55.12% | +33.21% | 3Cr |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- A221800 Stock
- Charts U2Bio Co., Ltd.
- Comparison Chart
